Treatment Options for Headache
For acute moderate-to-severe migraine, start with combination therapy of a triptan plus an NSAID (or acetaminophen if NSAIDs are contraindicated), as this provides superior pain relief compared to monotherapy and should be initiated as early as possible after headache onset. 1
Acute Treatment Algorithm
First-Line Therapy
Mild Episodic Migraine:
- Use an NSAID alone (ibuprofen, naproxen, diclofenac, aspirin, or celecoxib), acetaminophen alone, or their combination 1
- Ensure adequate dosing before escalating therapy 1
Moderate-to-Severe Episodic Migraine:
- Initiate combination therapy immediately: Triptan + NSAID (or triptan + acetaminophen when NSAIDs contraindicated) 1
- Available triptans include: almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, sumatriptan, or zolmitriptan 1
- Route of administration should be individualized based on patient preference and cost 1
Second-Line Options (After Triptan + NSAID/Acetaminophen Failure)
If patients do not tolerate or have inadequate response to combination therapy:
- CGRP antagonists (gepants): rimegepant, ubrogepant, or zavegepant 1
- Ergot alkaloid: dihydroergotamine 1
Third-Line Option
- Lasmiditan (5-HT1F agonist): Reserved for patients who fail all other pharmacologic treatments in this guideline 1
Special Circumstances
Severe Nausea/Vomiting:
- Use nonoral triptan formulations plus an antiemetic 1
Cardiovascular Risk Factors:
- Avoid triptans due to vasoconstrictive properties 2
- Consider lasmiditan, which appears safe in patients with cardiovascular risk 2
Treatments to AVOID
Never use opioids or butalbital for acute episodic migraine treatment 1 - these medications do not improve outcomes and increase risk of medication overuse headache.
Tension-Type Headache Treatment
Acute Treatment:
- Ibuprofen 400 mg or acetaminophen 1000 mg 1
Chronic Tension-Type Headache Prevention:
- Amitriptyline 1
Migraine Prevention
When episodic migraines occur frequently or acute treatment provides inadequate response, add preventive medications 1:
Episodic Migraine Prevention Options:
- Angiotensin-receptor blockers, lisinopril 1
- Topiramate, valproate, memantine 1
- Magnesium 1
- CGRP monoclonal antibodies (galcanezumab, fremanezumab, eptinezumab, erenumab) 1
- Atogepant (oral gepant) 1
Chronic Migraine Prevention:
Do NOT use gabapentin for episodic migraine prevention 1
Non-Pharmacologic Interventions
- Physical therapy or aerobic exercise for both tension-type headache and migraine management 1
- Lifestyle modifications: adequate hydration, regular meals, consistent sleep, regular moderate-to-intense aerobic exercise, stress management with relaxation/mindfulness techniques, weight loss if overweight/obese 1
Critical Safety Considerations
Medication Overuse Headache:
- Defined as headache occurring ≥15 days/month for ≥3 months due to acute medication overuse 1
- Thresholds vary: ≥15 days/month with NSAIDs; ≥10 days/month with triptans 1
- Patients overusing acute medications should stop entirely and consider prophylactic treatment 1
Pregnancy and Lactation:
- Discuss adverse effects of all pharmacologic treatments with patients of childbearing potential, those pregnant, or breastfeeding 1
Cost Considerations
Prescribe less costly recommended medications when appropriate 1 - generic triptans and NSAIDs are significantly more cost-effective than newer CGRP antagonists (gepants have annualized costs of $4,959-$8,800) 1